02 Mar, 10:29 - Indian

Nifty 50 24864.6 (-1.25)

Nifty IT 30507.35 (-0.32)

Nifty Next 50 68840.5 (-1.25)

Nifty Smallcap 100 16771.85 (-0.93)

SENSEX 80266.08 (-1.26)

Nifty Bank 59820.75 (-1.17)

Nifty Midcap 100 58600.25 (-0.87)

Nifty Pharma 22779.5 (-0.75)

02 Mar, 10:29 - Global

NIKKEI 225 57882.24 (-1.64)

HANG SENG 26190.27 (-1.65)

S&P 6840.5 (-0.88)


Pre Session News

You are Here : Home > News > Pre Session News >

(02 Mar 2026, 07:50)

Stock Alert: Aurobindo Pharma, Oriental Rail, ITCONS E-Solution, SWPE, Artefact Projects


Securities in F&O Ban:

Shares of Sammaan Capital will be banned from F&O trading on Monday 02 March 2026.

IPO Listing:

Shree Ram Twistex will make its debut on the stock exchanges on Monday. The issue was subscribed 43.66 times. The issue opened for bidding on 23 February 2026, and it closed on 25 February 2026.

Clean Max Enviro Energy Solutions will make its debut on the stock exchanges on Monday. The issue was subscribed 0.94 times. The issue opened for bidding on 23 February 2026 and it closed on 25 February 2026.

Stocks to Watch:

Auto stocks likely to remain focus as they will declare monthly auto sales data.

Oriental Rail Infrastructure has secured an order worth Rs 1.73 crore from the Integral Coach Factory (ICF), Chennai, a unit of Indian Railways. The contract involves the manufacturing, supply and installation of 13 sets of “one coach set of seats and berths with hardware.” The order is to be executed by March 29, 2026.

Artefact Projects has secured a consultancy services contract worth Rs 3.53 crore from the National Highways Authority of India (NHAI). The contract has been awarded by a domestic entity and will be executed over a period of 36 months.

ITCONS E-Solution has secured an order worth Rs 2.62 crore from Hindustan Aeronautics (HAL), under the Department of Defence Production, Ministry of Defence. The contract involves deployment of 43 resources for a period of two years. It will commence on 3 March 2026 and remain valid till 2 March 2028, unless extended by mutual agreement between the parties.

Aurobindo Pharma has informed that the USFDA inspection concluded with four observations at a formulation manufacturing facility of its wholly owned subsidiary, Eugia Pharma Specialities, in Telangana.

Kabra Extrusiontechnik has secured an order worth approximately Rs 133 crore from a domestic customer for energy storage solutions. The contract pertains to contract manufacturing and is scheduled to be executed during FY 2026–27. Due to confidentiality obligations and commercial sensitivity, the name of the customer has not been disclosed.

South West Pinnacle Exploration (SWPE) has secured a work order worth Rs 307 crore from Hind Metal Exploration Services (HMESPL), a wholly-owned subsidiary of Hindustan Zinc, for mineral exploration services in Rajasthan.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +